MedPath

Effects of Vanilla on Hypoxic Intermittent Events in Premature Infants

Not Applicable
Completed
Conditions
Neonatal Hypoxic Conditions
Premature Birth
Interventions
Other: Vanilla scent
Registration Number
NCT02630147
Lead Sponsor
Université de Sherbrooke
Brief Summary

The purpose of this study is to evaluate the effect of vanilla odor on hypoxic intermittent events in premature infants born between 32.0 and 33.6 weeks of gestational age.

Detailed Description

A weekly screening will be done on all new hospitalized infants at the neonatal care unit of the CHUS born between 32.0 and 33.6 weeks of gestational age. At the beginning of their 2nd week in the neonatal care unit, infant's medical record will be consulted for inclusion and exclusion criteria. At this moment, no information will be noted. Then, team research will discuss with neonatologist to have their opinion concerning the inclusion of a patient in the study. If they agree, the doctor or the nurse having a therapeutic link with the infant will ask parents' infant if they agree to meet the research team to discuss about the research project. Once the agreement will be obtained, parents will be approached by a member of the research team. Project will be explained, questions will be answered and consent form will be obtained. When an infant will be enrolled in the study, a code will be attributed to him and a randomization will established the order of the intervention.

Option A) night 1: a 12h cardiorespiratory recording with vanilla, night 2: no recording and night 3: a 12h cardiorespiratory recording without vanilla OR Option B): night 1: a 12h cardiorespiratory recording without vanilla, night 2: no recording and night 3: a 12h cardiorespiratory recording recording with vanilla.

All data will be entered in a secured database and a double checked will be done by team members to assess the accuracy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Infants born between 30.0 and 34.0 weeks of gestational age;
  • Postnatal age between 3 and 4 weeks;
  • No current respiratory or ventilatory support;
  • Stable state for at least the last 48 hours;
  • Parental consent to enroll in the study.
Exclusion Criteria
  • Respiratory diseases other than apnea;
  • Intraventricular hemorrhage grade 3 or 4 OR leukomalacia;
  • Chromosomal abnormality;
  • Congenital malformations which may result in cardiorespiratory or neurodevelopmental abnormality;
  • Clinical deterioration during the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Vanilla, Then no vanilla nightVanilla scentParticipants were exposed to vanilla odor (2 mL of 2% vanillin on the bib, close to the face) on the first night (12-hour recording), and not exposed to vanilla on the third night (control night,12-hour recording) No intervention, no recordings were made on the second night
No vanilla, Then vanilla nightVanilla scentParticipants were exposed to the "control" condition on the first night, which consisted of no vanilla odor (12-hour recording), and then exposed to vanilla odor on the third night (2 mL of 2% vanillin on the bib, close to the face;12-hour recording) No intervention, no recordings were made on the second night
Primary Outcome Measures
NameTimeMethod
Desaturation Index12 hour period of recording on the night 1 and 3 of each participants, in which they are exposed to vanilla or no vanilla odor

Number per hour of oxygen saturation \< 90% for at least 5 seconds

Secondary Outcome Measures
NameTimeMethod
Percentage of Time of Oxygen Saturation Under 90%12 hour period of recording on the night 1 and 3 of each participants, in which they are exposed to vanilla or no vanilla odor

Percentage time in overall duration of oxygen saturation under 90%

Percentage of Time of Periodic Breathing12 hour period of recording on the night 1 and 3 of each participants, in which they are exposed to vanilla or no vanilla odor

Percent of time of the recording spent in periodic breathing or in apnea.

A periodic beathing epoch was defined as a series of 3 episodes or more of apneas lasting at least 3 seconds and separated by less than 20 seconds of normal breathing

Apneas were defined as the absence of respiratory movements for at least 20 seconds or for at least 2 breathing cycles with a decrease of at least 3% in SpO2

Time in Apnea12 hour period of recording on the night 1 and 3 of each participants, in which they are exposed to vanilla or no vanilla odor

Percent of time of the recording spent in apnea

Mean SpO212 hour period of recording on the night 1 and 3 of each participants, in which they are exposed to vanilla or no vanilla odor

Mean value of oxygen saturation (%)

Trial Locations

Locations (1)

Nicu - Chus

🇨🇦

Sherbrooke, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath